Terms: = Thyroid cancer AND CDKN1B, CDKN4, 1027, ENSG00000111276, MEN4, P27KIP1, P46527, MEN1B, KIP1 AND Treatment
25 results:
1. Regional Collaboration and Trends in Clinical Management of thyroid cancer.
van Dijk SPJ; Coerts HI; Lončar I; van Kinschot CMJ; von Meyenfeldt EM; Edward Visser W; van Noord C; Zengerink HF; Ten Broek MRJ; Verhoef C; Peeters RP; van Ginhoven TM
Otolaryngol Head Neck Surg; 2024 Jan; 170(1):159-168. PubMed ID: 37595096
[TBL] [Abstract] [Full Text] [Related]
2. Efficacy on radiofrequency ablation according to the types of benign thyroid nodules.
Li J; Xue W; Xu P; Deng Z; Duan C; Zhang D; Zheng S; Cui K; Qiu X
Sci Rep; 2021 Nov; 11(1):22270. PubMed ID: 34782643
[TBL] [Abstract] [Full Text] [Related]
3. Primary hyperparathyroidism: Disease of diverse genetic, symptomatic, and biochemical phenotypes.
Medina JE; Randolph GW; Angelos P; Zafereo ME; Tufano RP; Kowalski LP; Montenegro FLM; Owen RP; Khafif A; Suárez C; Shaha AR; Rodrigo JP; Krempl GA; Rinaldo A; Silver CE; Ferlito A
Head Neck; 2021 Dec; 43(12):3996-4009. PubMed ID: 34541734
[TBL] [Abstract] [Full Text] [Related]
4. Achalasia and acromegaly: Co-incidence of these diseases or a new syndrome?
Dolina J; Kunovsky L; Kroupa R; Stary K; Jabandziev P; Nesporova T; Maca K; Andrasina T; Marek F; Kala Z; Vaculova J; Said D; Zapletalova M; Lochman J; Palova Noskova H; Slaby O; Izakovicova Holla L; Borilova Linhartova P
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2022 May; 166(2):228-235. PubMed ID: 34282806
[TBL] [Abstract] [Full Text] [Related]
5. High thyroglobulin and negative whole-body scan: no long-term benefit of empiric radioiodine therapy.
Tramontin MY; Nobre GM; Lopes M; Carneiro MP; Alves PAG; de Andrade FA; Vaisman F; Corbo R; Bulzico D
Endocrine; 2021 Aug; 73(2):398-406. PubMed ID: 33570724
[TBL] [Abstract] [Full Text] [Related]
6. Synergistic Combination of Histone Deacetylase Inhibitor Suberoylanilide Hydroxamic Acid and Natural Flavonoid Curcumin Exhibits Anticancer and Antibacterial Activity.
Altundağ EM; Toprak K; Şanlıtürk G; Güran M; Özbilenler C; Kerküklü NR; Yılmaz AM; Yalçın AS
Anticancer Agents Med Chem; 2021; 21(10):1301-1308. PubMed ID: 33023457
[TBL] [Abstract] [Full Text] [Related]
7. Nedd8-activating enzyme inhibitor MLN4924 (Pevonedistat), inhibits miR-1303 to suppress human breast cancer cell proliferation via targeting p27
Chen Y; Du M; Yusuying S; Liu W; Tan Y; Xie P
Exp Cell Res; 2020 Jul; 392(2):112038. PubMed ID: 32360865
[TBL] [Abstract] [Full Text] [Related]
8. Genetics of medullary thyroid cancer: An overview.
Accardo G; Conzo G; Esposito D; Gambardella C; Mazzella M; Castaldo F; Di Donna C; Polistena A; Avenia N; Colantuoni V; Giugliano D; Pasquali D
Int J Surg; 2017 May; 41 Suppl 1():S2-S6. PubMed ID: 28506408
[TBL] [Abstract] [Full Text] [Related]
9. Novel analogs targeting histone deacetylase suppress aggressive thyroid cancer cell growth and induce re-differentiation.
Jang S; Yu XM; Odorico S; Clark M; Jaskula-Sztul R; Schienebeck CM; Kupcho KR; Harrison AD; Winston-McPherson GN; Tang W; Chen H
Cancer Gene Ther; 2015 Aug; 22(8):410-6. PubMed ID: 26251030
[TBL] [Abstract] [Full Text] [Related]
10. Carfilzomib is an effective anticancer agent in anaplastic thyroid cancer.
Mehta A; Zhang L; Boufraqech M; Zhang Y; Patel D; Shen M; Kebebew E
Endocr Relat Cancer; 2015 Jun; 22(3):319-29. PubMed ID: 25972243
[TBL] [Abstract] [Full Text] [Related]
11. Cell cycle deregulation and TP53 and RAS mutations are major events in poorly differentiated and undifferentiated thyroid carcinomas.
Pita JM; Figueiredo IF; Moura MM; Leite V; Cavaco BM
J Clin Endocrinol Metab; 2014 Mar; 99(3):E497-507. PubMed ID: 24423316
[TBL] [Abstract] [Full Text] [Related]
12. FOXO1 controls thyroid cell proliferation in response to TSH and IGF-I and is involved in thyroid tumorigenesis.
Zaballos MA; Santisteban P
Mol Endocrinol; 2013 Jan; 27(1):50-62. PubMed ID: 23160481
[TBL] [Abstract] [Full Text] [Related]
13. Assessment of biomarkers for clinical diagnosis of papillary thyroid carcinoma with distant metastasis.
Liang H; Zhong Y; Luo Z; Huang Y; Lin H; Luo M; Zhan S; Xie K; Ma Y; Li QQ
Int J Biol Markers; 2010; 25(1):38-45. PubMed ID: 20306451
[TBL] [Abstract] [Full Text] [Related]
14. Proliferation and survival molecules implicated in the inhibition of BRAF pathway in thyroid cancer cells harbouring different genetic mutations.
Preto A; Gonçalves J; Rebocho AP; Figueiredo J; Meireles AM; Rocha AS; Vasconcelos HM; Seca H; Seruca R; Soares P; Sobrinho-Simões M
BMC Cancer; 2009 Oct; 9():387. PubMed ID: 19878585
[TBL] [Abstract] [Full Text] [Related]
15. FOXA1 is a potential oncogene in anaplastic thyroid carcinoma.
Nucera C; Eeckhoute J; Finn S; Carroll JS; Ligon AH; Priolo C; Fadda G; Toner M; Sheils O; Attard M; Pontecorvi A; Nose V; Loda M; Brown M
Clin Cancer Res; 2009 Jun; 15(11):3680-9. PubMed ID: 19470727
[TBL] [Abstract] [Full Text] [Related]
16. Suberoyl bishydroxamic acid activates notch1 signaling and suppresses tumor progression in an animal model of medullary thyroid carcinoma.
Ning L; Jaskula-Sztul R; Kunnimalaiyaan M; Chen H
Ann Surg Oncol; 2008 Sep; 15(9):2600-5. PubMed ID: 18563491
[TBL] [Abstract] [Full Text] [Related]
17. Regulation of p27kip1 protein levels contributes to mitogenic effects of the RET/PTC kinase in thyroid carcinoma cells.
Vitagliano D; Carlomagno F; Motti ML; Viglietto G; Nikiforov YE; Nikiforova MN; Hershman JM; Ryan AJ; Fusco A; Melillo RM; Santoro M
Cancer Res; 2004 Jun; 64(11):3823-9. PubMed ID: 15172989
[TBL] [Abstract] [Full Text] [Related]
18. p27(kip1) induces quiescence and growth factor insensitivity in tamoxifen-treated breast cancer cells.
Carroll JS; Lynch DK; Swarbrick A; Renoir JM; Sarcevic B; Daly RJ; Musgrove EA; Sutherland RL
Cancer Res; 2003 Aug; 63(15):4322-6. PubMed ID: 12907598
[TBL] [Abstract] [Full Text] [Related]
19. The selective tyrosine kinase inhibitor, STI571, inhibits growth of anaplastic thyroid cancer cells.
Podtcheko A; Ohtsuru A; Tsuda S; Namba H; Saenko V; Nakashima M; Mitsutake N; Kanda S; Kurebayashi J; Yamashita S
J Clin Endocrinol Metab; 2003 Apr; 88(4):1889-96. PubMed ID: 12679488
[TBL] [Abstract] [Full Text] [Related]
20. An adenovirus carrying the rat protein tyrosine phosphatase eta suppresses the growth of human thyroid carcinoma cell lines in vitro and in vivo.
Iuliano R; Trapasso F; Le Pera I; Schepis F; Samà I; Clodomiro A; Dumon KR; Santoro M; Chiariotti L; Viglietto G; Fusco A
Cancer Res; 2003 Feb; 63(4):882-6. PubMed ID: 12591742
[TBL] [Abstract] [Full Text] [Related]
[Next]
